{"article_id": "IFF_q4_2020.txt", "article": ["iff generated usd5.1 billion in sales for the full year 2020 , about a 1 % increase on a currency - neutral basis from last year when excluding the 53rd week of 2019 .", "we achieved an adjusted operating margin , excluding amortization , of 18.1 % , driven by our synergy efforts with frutarom and pursuing additional productivity initiatives across the business .", "we finished the year with an adjusted earnings per share , excluding amortization , of $ 5.70 .", "reflecting on 2020 , we were off to a very strong start , growing 6 % in q1 2020 , until the pandemic had a profound impact on society and , ultimately , our business .", "our growth rates continued to improve in the fourth quarter , up 2 % excluding the 53rd week , versus the 1 % year - on - year growth seen in the third quarter .", "as we have noted before , roughly 15 % of our business was negatively impacted by covid - 19 and decreased by 16 % in 2020 , excluding the impact of the 53rd week .", "this was roughly 85 % of our pre-pandemic sales and these grew approximately 4 % for the full year , excluding the impact of the 53rd week .", "as we begin 2021 , i 'm very pleased to say we , on a combined company basis , had a strong performance in january , with approximately 3 % currency - neutral growth against a strong year - ago comparison .", "in the fourth quarter , iff generated $ 1.3 billion in sales , down 2 % year - over - year on a currency - neutral basis .", "when excluding the roughly $ 50 million impact of 2019 's 53rd week , our comparable currency - neutral growth was plus 2 % , and as i 'll explain on the next slide , up approximately 4 % , counting foreign exchange - related price changes as our peers in many cpgs disclosed .", "in the fourth quarter , our adjusted operating profit , excluding amortization , decreased by 10 % on a currency - neutral basis , or by 9 % including a one percentage point benefit of fx , with solid operating performance -- operational performance offset by a challenging year - ago comparable and covid costs .", "we delivered adjusted earnings per share , excluding amortization , of $ 1.32 , mostly as a result of lower operating profit in the quarter .", "this was down 11 % on a currency - neutral basis , or 10 % including the one percentage point benefit of fx .", "to be clear , if we simply looked at our revenue in the current period by local currency and applied the average fx rates from the prior period to the current period , our currency - neutral growth of 2 % in the fourth quarter would have been up approximately 4 % , and our full year currency - neutral growth of 1 % would go to approximately 3 % , all excluding the impact of the 53rd week .", "at the segment level , scent would have grown 10 % in q4 2020 and 7 % in the full financial year , while taste would have been up 1 % in both q4 and the full year 2020 .", "a close look at our operating profit bridge shows that we were able to drive operational improvements , about 8 % , largely attained through frutarom synergy realization , productivity initiatives and reformulation activities , mostly in scent ; higher volumes ex the 53rd week and disciplined cost management .", "unfortunately , these combined items represent an 18 percentage point year - over - year headwind and were the primary driver of our 10 % currency - neutral decline in operating profit .", "sales totaling $ 504 million were up 3 % , or 7 % when excluding the 53rd week comparison .", "also , the new color is , where we recently gained access in consumer fragrance , core to our 2021 strategy , grew more than 60 % in the fourth quarter and represented more than 1/3 of our consumer fragrance growth .", "so overall , the scent division achieved a 15.9 % profit margin on the $ 504 million of sales in the quarter .", "taste sales totaling $ 766 million declined 5 % , or 1 % when excluding the 53rd week comparison .", "food service was down roughly 17 % on a similar basis .", "the taste division achieved approximately 11.8 % profit margin , with $ 90 million in segment profit .", "these numbers also include approximately $ 42 million in amortization of intangible assets .", "if you exclude that amortization , our q4 margin would be 17.2 % .", "as you will see , operating cash flow for the full year was up from $ 699 million in 2019 to $ 714 million this year , an increase of 2 % .", "we also reduced our capex to 3.8 % of sales versus 4.6 % of sales in the prior year period as we prioritized spending more than ever to manage and preserve cash through the pandemic .", "all this led to a significant 13 % increase in free cash flow compared to 2020's $ 522 million .", "assumed in our full year guidance is a euro to u.s. dollar exchange rate of $ 1.18 , which represents approximately 25 % of our combined sales .", "we expect approximately $ 50 million of merger - related cost synergies with dupont n&b , mostly back - end loaded this year , with $ 45 million coming from cost synergies and an additional $ 5 million from the ebitda contribution of revenue synergies .", "we expect total annual depreciation and amortization to be $ 1.165 billion , which includes amortization of approximately $ 715 million .", "annual interest expense is expected to be around $ 315 million .", "lastly , we expect diluted shares outstanding for the pro forma company , for earnings per share calculation purposes , to be approximately 255 million shares , and that 's including the approximately 141 million shares from the transaction .", "in line with the projections included in our december 22 s - 4 filing , plus the synergy realization plan communicated january 11 , we expect to generate approximately $ 11.5 billion in sales at an approximately 23.2 % adjusted ebitda margin .", "please note that this is a 12 - month combined company pro forma estimate and includes approximately $ 507 million of n&b sales that occurred in january 2021 .", "on a pro forma basis , sales are expected to grow nearly 4 % and ebitda margin to expand by approximately 100 basis points .", "as we face a strong first quarter comparison from both iff at 6 % and n&b at 3 % , we will also continue -- we also continue to manage through pandemic - related headwinds .", "building on what andreas said earlier , i 'm pleased to say that we had solid pro forma results in january , with approximately 3 % currency - neutral growth on our new disclosure basis .", "in january 2021 , n&b finished with approximately $ 507 million in sales .", "while this has no impact on our full year expected sales , please remember that we moved away from our previous 4 , 4 , five reporting cycle to calendar month reporting from january .", "we 've shifted from our previous financial reporting calendar of 4 , 4 , five weeks to the more commonly used calendar month end to eliminate comparable issues related to the 53rd week .", "our r&d investment will be 1.5 times greater than our nearest peer .", "we will have # 1 or # 2 positions in core categories in nutrition , cultures , enzymes , probiotics , soy proteins , flavors and fragrances .", "this is coupled with the broadest and most diverse customer base in our industry , more than 45,000 in total , and about 48 % of our annual sales from small medium and private label customers .", "we expect that execution on our plan will unlock about $ 50 million in ebitda contribution in 2021 .", "and we -- and as we mentioned on january 11th , there are 85 separate initiatives behind the $ 300 million cost savings that are in our plan on the cost side and another several initiatives on the revenue side .", "from a revenue perspective , we expect currency - neutral organic sales growth of approximately 4 % to 5 % over the next few years , led by our unrivaled product and solutions portfolio , which is set to benefit from our industry - leading r&d programs .", "we also expect to see meaningful operating margin improvements for iff , including an estimated adjusted ebitda margin of approximately 26 % in 2023 , up around 400 basis points from our 2020 pro forma .", "the new iff will continue to generate strong free cash flows , and we expect a significant increase to approximately $ 2 billion in 2023 .", "we are targeting almost 3 times net debt - to - ebitda ratio , 24 to 36 months post close and reaffirm our commitment to maintaining our investment - grade rating ."], "summary_gold": "sees 2021 pro-forma ( giving effect to n&b transaction ) sales to be approximately $ 11.5 billion .", "summary_pred": "we expect total annual depreciation and amortization to be $ 1.165 billion , which includes amortization of approximately $ 715 million .<q>annual interest expense is expected to be around $ 315 million .<q>in line with the projections included in our december 22 s - 4 filing , plus the synergy realization plan communicated january 11 , we expect to generate approximately $ 11.5 billion in sales at an approximately 23.2 % adjusted ebitda margin .<q>so overall , the scent division achieved a 15.9 % profit margin on the $ 504 million of sales in the quarter .<q>we expect approximately $ 50 million of merger - related cost synergies with dupont n&b , mostly back - end loaded this year , with $ 45 million coming from cost synergies and an additional $ 5 million from the ebitda contribution of revenue synergies .<q>please note that this is a 12 - month combined company pro forma estimate and includes approximately $ 507 million of n&b sales that occurred in january 2021 .<q>our growth rates continued to improve in the fourth quarter , up 2 % excluding the 53rd week , versus the 1 % year - on - year growth seen in the third quarter .<q>our r&d investment will be 1.5 times greater than our nearest peer .<q>we will have # 1 or # 2 positions in core categories in nutrition , cultures , enzymes , probiotics , soy proteins , flavors and fragrances .<q>food service was down roughly 17 % on a similar basis .<q>assumed in our full year guidance is a euro to u.s. dollar exchange rate of $ 1.18 , which represents approximately 25 % of our combined sales .<q>we finished the year with an adjusted earnings per share , excluding amortization , of $ 5.70 .<q>reflecting on 2020 , we were off to a very strong start , growing 6 % in q1 2020 , until the pandemic had a profound impact on society and , ultimately , our business .<q>all this led to a significant 13 % increase in free cash flow compared to 2020's $ 522 million .<q>at the segment level , scent would have grown 10 % in q4 2020 and 7 % in the full financial year , while taste would have been up 1 % in both q4 and the full year 2020 .<q>on a pro forma basis , sales are expected to grow nearly 4 % and ebitda margin to expand by approximately 100 basis points .", "len_article": 50, "len_summary_gold": 1, "len_summary_pred": 16, "len_sent_scores": 50}